Zimmer Biomet Holdings, Inc. (BIT:1ZBH)
Italy · Delayed Price · Currency is EUR 80.94
+4.26 (5.56%)
Last updated: Feb 10, 2026, 3:23 PM CET
Zimmer Biomet Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,232 | 7,679 | 7,394 | 6,940 | 6,827 | |
Revenue Growth (YoY) | 7.20% | 3.85% | 6.55% | 1.65% | 11.42% |
Cost of Revenue | 2,287 | 2,180 | 2,076 | 2,020 | 1,960 |
Gross Profit | 5,944 | 5,499 | 5,319 | 4,920 | 4,867 |
Selling, General & Admin | 3,252 | 2,876 | 2,793 | 2,668 | 2,626 |
Research & Development | 458.5 | 437.4 | 458.7 | 406 | 435.8 |
Amortization of Goodwill & Intangibles | 665.9 | 591.9 | 561.5 | 526.8 | 529.5 |
Other Operating Expenses | - | - | - | 33.8 | 52.8 |
Operating Expenses | 4,376 | 3,905 | 3,813 | 3,634 | 3,645 |
Operating Income | 1,568 | 1,594 | 1,505 | 1,286 | 1,222 |
Interest Expense | -292.8 | -218 | -201.2 | -164.8 | -208.4 |
Currency Exchange Gain (Loss) | - | -15.6 | -17.2 | -19.7 | -5.5 |
Other Non Operating Income (Expenses) | 25.4 | 3 | -0.3 | -0.5 | 1.7 |
EBT Excluding Unusual Items | 1,300 | 1,363 | 1,287 | 1,101 | 1,010 |
Merger & Restructuring Charges | -464.4 | -247 | -181.8 | -203 | -125.7 |
Impairment of Goodwill | - | - | - | -289.8 | - |
Gain (Loss) on Sale of Investments | - | -42.1 | -16 | -136 | - |
Legal Settlements | -5.2 | -30.5 | -21.6 | -65.9 | -201 |
Other Unusual Items | - | -7.1 | - | - | -168.2 |
Pretax Income | 830.7 | 1,037 | 1,067 | 403.5 | 499 |
Income Tax Expense | 125.7 | 131.4 | 42.2 | 112.3 | 53.5 |
Earnings From Continuing Operations | 705 | 905.3 | 1,025 | 291.2 | 445.5 |
Earnings From Discontinued Operations | - | - | - | -58.8 | -43.4 |
Net Income to Company | 705 | 905.3 | 1,025 | 232.4 | 402.1 |
Minority Interest in Earnings | 0.1 | -1.5 | -1.1 | -1 | -0.5 |
Net Income | 705.1 | 903.8 | 1,024 | 231.4 | 401.6 |
Net Income to Common | 705.1 | 903.8 | 1,024 | 231.4 | 401.6 |
Net Income Growth | -21.98% | -11.74% | 342.52% | -42.38% | - |
Shares Outstanding (Basic) | 198 | 203 | 209 | 210 | 209 |
Shares Outstanding (Diluted) | 199 | 204 | 210 | 210 | 210 |
Shares Change (YoY) | -2.55% | -2.77% | -0.29% | -0.05% | 1.64% |
EPS (Basic) | 3.56 | 4.45 | 4.91 | 1.10 | 1.93 |
EPS (Diluted) | 3.55 | 4.43 | 4.88 | 1.10 | 1.91 |
EPS Growth | -19.86% | -9.22% | 343.48% | -42.50% | - |
Free Cash Flow | 1,172 | 1,055 | 978.8 | 838.5 | 1,082 |
Free Cash Flow Per Share | 5.90 | 5.18 | 4.67 | 3.99 | 5.14 |
Dividend Per Share | 0.960 | 0.960 | 0.960 | 0.960 | 0.960 |
Gross Margin | 72.21% | 71.61% | 71.93% | 70.90% | 71.29% |
Operating Margin | 19.05% | 20.76% | 20.36% | 18.53% | 17.90% |
Profit Margin | 8.57% | 11.77% | 13.85% | 3.33% | 5.88% |
Free Cash Flow Margin | 14.24% | 13.74% | 13.24% | 12.08% | 15.85% |
EBITDA | 2,662 | 2,590 | 2,457 | 2,213 | 2,160 |
EBITDA Margin | 32.33% | 33.73% | 33.23% | 31.88% | 31.64% |
D&A For EBITDA | 1,094 | 996.3 | 951.7 | 926.4 | 937.7 |
EBIT | 1,568 | 1,594 | 1,505 | 1,286 | 1,222 |
EBIT Margin | 19.05% | 20.76% | 20.36% | 18.53% | 17.90% |
Effective Tax Rate | 15.13% | 12.68% | 3.95% | 27.83% | 10.72% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.